# Scientific Health Development

Scientific Health Development is a Venture Capital based in Dallas, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Dallas, United States
- **Region:** North America
- **Address:** 8144 Walnut Hill Ln., Suite 905, Dallas, TX 75231, United States
- **Founded:** 2006
- **Assets under management:** Undisclosed
- **Website:** www.shdpartners.com
- **LinkedIn:** https://www.linkedin.com/company/scientific-health-development

## Regulatory record

- **Reports private funds:** No

## About

Scientific Health Development is a boutique investment company based in Dallas, TX. It invests in early-stage healthcare technologies and products. SHD has made 50 investments, including a Series A - II investment in Cooler Heads on May 07, 2025.

## Sectors

- Medical Devices
- Healthcare Services

## People

- Philip Romano — Co-Founder
- Stuart Fitts — Co-Founder
- Andrew Offer — Managing Partner
- Mike Schotzinger — Team Member

## Questions

### Who runs investment decisions at Scientific Health Development?

Managing Partner Andrew Offer leads the day-to-day investment process. He joined founders Philip Romano and Stuart Fitts in 2007, bringing a background in healthcare valuation and reimbursement analysis. The four-person team listed publicly also includes Mike Schotzinger.

### What is Scientific Health Development's connection to the Palmaz stent?

Philip Romano was the sole outside investor in Julio Palmaz before the Palmaz stent became the world's first commercially approved coronary stent and created a multi-billion-dollar market. That angel success gave Romano and Stuart Fitts both the capital and conviction to launch SHD in 2006 as a dedicated medtech venture firm.

### Does Scientific Health Development participate in fund commitments or only direct deals?

SHD invests directly in early-stage medtech companies rather than making fund commitments. The firm describes its strategy as providing limited partners with exposure to private medical-device companies that can reach value-inflection points and exits within a relatively compressed timeline.

### What investment stages does Scientific Health Development target?

SHD targets seed and start-up rounds, concentrating on companies that require smaller amounts of funding. The firm looks for technologies with attainable, near-term regulatory or clinical milestones, which separates it from venture firms that focus on longer-gestation therapeutic drug development.

### What is SHD's known posture on co-investments alongside external GPs?

The firm does not publicly describe a co-investment program. Its primary model is direct capital deployment into portfolio companies, with the investment team providing operational support in areas such as reimbursement strategy, financial planning, and governance.

## Related profiles

- [Scientifica Venture Capital](https://altss.com/profile/scientifica-venture-capital)
- [Scientipole Capital](https://altss.com/profile/scientipole-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/scientific-health-development

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology